Phase
Condition
Healthy Volunteers
Treatment
Placebo
ORKA-001
Clinical Study ID
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Healthy male or female participants
18 to 65 years (inclusive) with a body mass index (BMI) 18 to 32 kg/m2
Willing and able to remain at the study site unit for the duration of theconfinement period and return for the outpatient visit/s defined in the protocol
Using a highly effective method of contraception from admission through the end ofthe study.
Willing to abstain from regular, continuous alcohol use or tobacco use as perprotocol
Exclusion
Key Exclusion Criteria:
Any clinically significant medical condition or finding that, in the Investigator'sopinion, is likely to unfavorably alter the risk of study participation, confoundstudy results, or interfere with the study conduct or compliance.
Known history of illicit drug use or drug abuse or harmful alcohol use
Known history of frequent tobacco or vaping use within 2 years prior to Screening
History of severe allergic reactions or hypersensitivity
Actively nursing or lactating
Use of investigational drug therapy within 30 days prior to enrollment
Unable to comply with study requirements or in the opinion of the Investigatorshould not participate in this study.
Study Design
Study Description
Connect with a study center
Oruka Therapeutics Investigative Site
Christchurch,
New ZealandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.